Therapeutic Efficacy of Moxifloxacin Mucoadhesive Hydrogel for Bacterial Keratitis

  • Nipuna Kumar Bhoi Lakshmi Narain College of Pharmacy, Bhopal, M.P, India
  • A. K. Singhai Lakshmi Narain College of Pharmacy, Bhopal, M.P, India
  • Gaurav Jain Lakshmi Narain College of Pharmacy, Bhopal, M.P, India
  • Subhendu S. Mishra Kalinga Biomedical Research Institute & Training Establishment, Sambalpur, Odisha, India

Abstract

Bacterial keratitis is a hypothetically devastating corneal infection due to the opportunity of fast development; corneal devastation either to be completed in 24–48 hours with even more contagious bacterial aetiological agents. Moxifloxacin mucoadhesive Hydrogel was prepared by using polymer Hydroxy Propyl Methyl Cellulose E50 LV by hydration method. Moxifloxacin was dissolved in small quantity of water and Benzalkonium Chloride was added to the Polymer solution. The formulations were evaluated for clarity, pH measurement, spread-ability test, drug content estimation, viscosity study, in vitro diffusion study and antibacterial activity. The developed formulation exhibits the sustained release over a period of 10 hour. The optimized formulation was further evaluated with antimicrobial activity. The results of the in-vitro antimicrobial activity of hydrogel were satisfactory.


Keywords: Corneal Infection, Hydrogel, Moxifloxacin, invitro release

Keywords: Corneal Infection, Hydrogel, Moxifloxacin, invitro release, Corneal Infection, Hydrogel, Moxifloxacin, invitro release

Downloads

Download data is not yet available.

Author Biographies

Nipuna Kumar Bhoi, Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

A. K. Singhai, Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

Gaurav Jain, Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

Lakshmi Narain College of Pharmacy, Bhopal, M.P, India

Subhendu S. Mishra, Kalinga Biomedical Research Institute & Training Establishment, Sambalpur, Odisha, India

Kalinga Biomedical Research Institute & Training Establishment, Sambalpur, Odisha, India

References

1. Schaftenaar E, Peters RPH, Baarsma GS, Meenken C, Khosa NS and Getu S. () Clinical and corneal microbial profile of infectious keratitis in a high HIV prevalence setting in rural South Africa. Eur J Clin Microbiol Infect Dis.2016; 35:1403-9.
2. Robles-Contreras A, Perez-Cano HJ, Babayan-Sosa A, Baca-Lozada O. Bacterial keratitis infection: A battle between virulence factors and the immune response, Common Eye Infections. Imtiaz Chaudhry, IntechOpen, DOI: 10.5772/52264.
3. Leck AK, ThomasPA, Hagan M.et al., Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. The British Journal of Ophthalmology.2002; 86 (11):1211–1215.
4. Pinna A, Zanetti S, Sotgiu M, Sechi LA, FaddaG, Carta F. Identification and antibiotic susceptibility of coagulase-negative staphylococci isolated in corneal/external infections. The British Journal of Ophthalmology.1999; 83(7):771–773.
5. ManikandanP, Bhaskar M, Revathy R, JohnRK, Narendran K, NarendranV. Speciation of coagulase-negative Staphylococcus causing bacterial keratitis.Indian Journal of Ophthalmology.2005; 53(1):59–60.
6. Ly AN, PhamJN, BadenochPR, et al. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin,” Clinical and Experimental Ophthalmology.2006; 34 (1):44–50.
7. JohnJF, HarvinAM. History and evolution of antibiotic resistance in coagulase-negative staphylococci: susceptibility profiles of new anti-staphylococcal agents. Therapeutics and Clinical Risk Management.2007; 3(6):1143–1152.
8. Schein OD, BuehlerPO, StamlerJF, VerdierDD, KatzJ. The impact of overnight wear on the risk of contact lens-associated ulcerative keratitis. Archives of Ophthalmology. 1994; 112 (2):186–190,.
9. Limberg MB. A review of bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol. 1991; 112:2S–9S.
10. Hägerström H.Edsman K. Strømme M. Low-frequency dielectric spectroscopy as a tool for studying the compatibility between pharmaceutical gels and mucus tissue. J. Pharm. Sci. 2003, 92:1869–1881.
11. Hanafy NAN, Quarta A, Ferraro MM, Dini L, Nobile C, De Giorgi ML. Carallo S, Citti C, Gaballo A, Cannazza G,et al. Polymeric Nano-MicellesasNovel Cargo-Carriers for LY2157299 LiverCancerCells Delivery. Int. J. Mol. Sci. 2018; 6:19.
12. Hanafy NAN, El-Kemary M, Leporatti S. Reduction diameter of CaCO3 crystals by using polyacrylic acid might improve cellular uptake of encapsulated curcumin in breast cancer. J. Nanomed. Res. 2018, 7:235–239.
13. Hanafy NA, DeGiorgi MLD, Nobile C, Rinaldi R, Leporatti S. Control of Colloidal CaCO3 suspension by using biodegradable polymers during fabrication. Beni-Suef Univ. J. Basic Appl. Sci. 2015; 4:60–70.
14. Preethi GB, Narendra E. Formulation and Evaluation of In Situ Mucoadhesive Ophthalmic Hydrogel for Sustained Delivery of Pefloxacin Mesylate. International Journal of Pharmacy and Pharmaceutical Sciences. 2015; 7(8):345-350.
15. Gokulgandhi MR, Parikh JR, Megha Barot M, Modi DM. A pH triggered in situ gel-forming ophthalmic drug delivery system for tropicamide. Drug Delivery Technology. 2007; 5:44-9.
16. Zhidong L, Jiawei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an alginate/HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm. 2006; 315:12-7.
17. Khanna R, Agarwal S P, Ahuja A. Preparation and evaluation of mucoadhesive buccal films of clotrimazole for oral Candida infections. Indian J Pharm Sci. 1997; 59:299-305.
18. Sultana Y, Aqil M, Ali A, Zafar S. Evaluation of carbopol‐methylcellulose based sustained‐release ocular delivery system for pefloxacin mesylate using rabbit eye model. Pharm Dev Technol. 2006; 11:313‐9.
19. Desi HA, Bhalla HL. Preparation and evaluation of a new eye drop containing a combination of ciprofloxacin and dexamethasone. Indian Drugs. 2000; 37:112.
Statistics
106 Views | 107 Downloads
How to Cite
1.
Bhoi NK, Singhai AK, Jain G, Mishra SS. Therapeutic Efficacy of Moxifloxacin Mucoadhesive Hydrogel for Bacterial Keratitis. JDDT [Internet]. 25Oct.2020 [cited 27Nov.2021];10(5-s):186-90. Available from: http://jddtonline.info/index.php/jddt/article/view/4369